Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Numinus Wellness Inc T.NUMI

Alternate Symbol(s):  NUMIF

Healthcare
Numinus Wellness Inc. is a mental health care company. The Company focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and... see more

Recent & Breaking News (TSX:NUMI)

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Canada NewsWire December 29, 2020

IIROC Trading Halt - NUMI

Canada NewsWire December 29, 2020

This is Why Psychedelics Could Be One of The Top Opportunities of 2021

Livemoney December 29, 2020

Numinus Completes First Extraction of its Psilocybe Mushrooms

Canada NewsWire December 17, 2020

Psychedelic Drugs Could Create a $100 Billion Investment Opportunity

Livemoney December 15, 2020

Numinus Wellness Announces National Expansion with Acquisition of Montreal-Based Mindspace Wellbeing, a Full-service Well-being Organization and Pioneer in Psychedelic Programming

Canada NewsWire December 15, 2020

IIROC Trading Resumption - NUMI

Canada NewsWire December 14, 2020

IIROC Trading Halt - NUMI

Canada NewsWire December 14, 2020

Numinus Wellness commends Health Canada for its intent to make MDMA and psilocybin treatment available through the Special Access Programme

Canada NewsWire December 11, 2020

Entheon Biomedical Announces DMT Drug Supply Agreement with Psygen Labs

Livemoney December 11, 2020

IIROC Trading Resumption - NUMI

Canada NewsWire December 7, 2020

Numinus Wellness Inc. Announces an Increase to the Previously Announced Bought Deal Public Offering

Canada NewsWire December 7, 2020

IIROC Trading Halt - NUMI

Canada NewsWire December 7, 2020

Numinus Rolls Out Public Offering to Advance Psychedelic Research

Stockhouse Editorial December 7, 2020

Numinus Wellness Inc. Announces $10 Million Bought Deal Public Offering

Canada NewsWire December 7, 2020

The StockTalk Cannabis Report: Dec. 4, 2020

Dave Jackson December 4, 2020

Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial

PR Newswire December 2, 2020

Psychedelic Drugs, Like MDMA Are Showing Signs of Helping with Mental Health Issues

Livemoney December 2, 2020

Meet a Pioneer Advancing Psilocybin-Assisted Psychotherapy

Stockhouse Editorial November 30, 2020

Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders

Canada NewsWire November 18, 2020